Oxidized-LDL and Paraoxonase-1 As Biomarkers of Coronary Artery Disease in Patients with Sleep-Disordered Breathing

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|25|4359-4366

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.25, 2012-09, pp. : 4359-4366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Opioids, Sleep, and Sleep-Disordered Breathing

By  

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1443-1449

Bentham Science Publishers

Access to resources Recommend Favorite

Methadone: Sleep-disordered breathing: case report

By  

Reactions Weekly, Vol. 1, Iss. 1288, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease

By Vogt Anja   Parhofer Klaus G  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 691-697

Informa Healthcare

Access to resources Recommend Favorite

The Role of Circadian Rhythms in Fatal Arrhythmias and the Potential Impact of Intervention for Sleep-Disordered Breathing

By  

Current Pharmaceutical Design, Vol. 21, Iss. 24, 2015-01 ,pp. : 3512-3522

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidized LDL, LOX-1 and Atherosclerosis

By Mitra Sona  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 5, 2011-10 ,pp. : 419-429

Springer Publishing Company

Access to resources Recommend Favorite